725 Pre-clinical development of TNFR2 ligand-blocking BI-1808 for cancer immunotherapy
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2020-11-01
|
Series: | Journal for ImmunoTherapy of Cancer |